Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hudson

Showing results (571-580 of 834) with videos related to

Pageof 84
Sort By:
British Journal of Plastic Surgery|August 6, 1999
Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanomaR Grover, J Chana, A O Grobbelaar, et al.
Urologic Oncology|March 20, 2013
Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?M'Liss A Hudson, Suhong Luo, Timothy Chrusciel, et al.
Journal of Gerontological Nursing|June 30, 2022
The Impact of Amplification on Cognitive Screening Test ScoresLaura Gaeta, Jo Azzarello, Jonathan Baldwin, et al.
Frontiers in Psychology|August 7, 2023
Adolescent: provider connectedness and STI risk reduction following a brief alcohol intervention: findings from a randomized controlled trialGenevieve F Dash, Angela D Bryan, Manshu Yang, et al.
Lupus|May 4, 2005
The dietary supplement ephedrine induces beta-adrenergic mediated exacerbation of systemic lupus erythematosus in NZM391 miceC A Hudson, T K Mondal, L Cao, et al.
Journal of Clinical Pharmacy and Therapeutics|February 1, 1990
A pharmacokinetic study of high-dose metoclopramide suppositoriesF Hardy, P S Warrington, J S MacPherson, et al.
Journal of the American Chemical Society|November 1, 2016
Targeting Reactive Carbonyls for Identifying Natural Products and Their Biosynthetic OriginsTucker Maxson, Jonathan I Tietz, Graham A Hudson, et al.
Addictive Behaviors|September 14, 2016
PTSD, alcohol dependence, and conduct problems: Distinct pathways via lability and disinhibitionJeffrey S Simons, Raluca M Simons, Carol O'Brien, et al.
Molecular Immunology|June 13, 2006
Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoterHan Chen, Carolyn A Gilbert, John A Hudson, et al.
Plastic and Reconstructive Surgery|February 3, 2009
Negative-pressure wound therapy II: negative-pressure wound therapy and increased perfusion. Just an illusion?Nicolas Kairinos, Anda M Voogd, Pieter H Botha, et al.
Pageof 84

Showing results (571-580 of 834) with videos related to

Sort By:
Pageof 84
British Journal of Plastic Surgery|August 6, 1999
Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanomaR Grover, J Chana, A O Grobbelaar, et al.
Urologic Oncology|March 20, 2013
Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?M'Liss A Hudson, Suhong Luo, Timothy Chrusciel, et al.
Journal of Gerontological Nursing|June 30, 2022
The Impact of Amplification on Cognitive Screening Test ScoresLaura Gaeta, Jo Azzarello, Jonathan Baldwin, et al.
Frontiers in Psychology|August 7, 2023
Adolescent: provider connectedness and STI risk reduction following a brief alcohol intervention: findings from a randomized controlled trialGenevieve F Dash, Angela D Bryan, Manshu Yang, et al.
Lupus|May 4, 2005
The dietary supplement ephedrine induces beta-adrenergic mediated exacerbation of systemic lupus erythematosus in NZM391 miceC A Hudson, T K Mondal, L Cao, et al.
Journal of Clinical Pharmacy and Therapeutics|February 1, 1990
A pharmacokinetic study of high-dose metoclopramide suppositoriesF Hardy, P S Warrington, J S MacPherson, et al.
Journal of the American Chemical Society|November 1, 2016
Targeting Reactive Carbonyls for Identifying Natural Products and Their Biosynthetic OriginsTucker Maxson, Jonathan I Tietz, Graham A Hudson, et al.
Addictive Behaviors|September 14, 2016
PTSD, alcohol dependence, and conduct problems: Distinct pathways via lability and disinhibitionJeffrey S Simons, Raluca M Simons, Carol O'Brien, et al.
Molecular Immunology|June 13, 2006
Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoterHan Chen, Carolyn A Gilbert, John A Hudson, et al.
Plastic and Reconstructive Surgery|February 3, 2009
Negative-pressure wound therapy II: negative-pressure wound therapy and increased perfusion. Just an illusion?Nicolas Kairinos, Anda M Voogd, Pieter H Botha, et al.
Pageof 84